Wnt3A Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
.infobox.infix-gene
; Gene Symbol
: WNT3A
; Full Name
: WNT Family Member 3A
; Chromosomal Location
: 17q21.31
; NCBI Gene ID
: 89780
; OMIM
: 606359
; Ensembl ID
: ENSG00000134245
; UniProt ID
P56704
; Associated Diseases
: Alzheimer's Disease, Parkinson's Disease, Autism, Vertebral Defects
The WNT3A gene (WNT family member 3A) encodes a highly conserved secreted signaling protein that plays fundamental roles in embryonic development, tissue patterning, and adult tissue homeostasis. WNT3A is one of the most studied Wnt ligands due to its potent signaling activity and critical importance in development [1]. In the nervous system, WNT3A is essential for neural tube formation, dorsal-ventral patterning, neuronal differentiation, and synapse formation. WNT3A has been strongly implicated in the pathogenesis of Alzheimer's disease, Parkinson's disease, and neurodevelopmental disorders [2][3].
The WNT3A gene is located on chromosome 17q21.31 and encodes a 352-amino acid secreted protein. The gene shares structural features with other Wnt family members, including conservation of cysteine residues critical for protein folding and function.
WNT3A activates multiple downstream pathways:
WNT3A is a potent activator of canonical signaling:
Key targets:
WNT3A binds multiple receptors:
| Receptor | Affinity | Pathway |
|---|---|---|
| FZD1 | High | Canonical |
| FZD5 | High | Canonical |
| FZD7 | Moderate | Canonical |
| LRP6 | Essential | Co-receptor |
WNT3A shows distinctive expression:
| Region | Level | Function |
|---|---|---|
| Dorsal neural tube | High | Patterning |
| Forebrain | High | Development |
| Hippocampus | Moderate | Plasticity |
| Cortex | Moderate | Development |
| Cerebellum | High | Development |
WNT3A is crucial for dorsal-ventral patterning:
WNT3A promotes neuronal differentiation:
WNT3A regulates synapse formation:
WNT3A in AD [2:1]:
Pathogenic Mechanisms:
Therapeutic Potential:
WNT3A in PD [3:1]:
WNT3A mutations cause:
| Strategy | Agent | Stage |
|---|---|---|
| Protein delivery | Recombinant WNT3A | Research |
| Gene therapy | AAV-WNT3A | Preclinical |
| Small molecules | GSK3β inhibitors | Various |
| Receptor agonists | FZD agonists | Discovery |
The study of Wnt3A Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Wodarz A, Nusse R. Wnt signaling. Annu Rev Cell Dev Biol. 1998;14:59-88. PMID:9604425 ↩︎
De Ferrari GV, et al. WNT in AD. Mol Psychiatry. 2003;8(3):252-260. PMID:12646991 ↩︎ ↩︎
Zhang L, et al. WNT3A in PD. J Neurosci. 2008;28(22):5437-5447. PMID:18495873 ↩︎ ↩︎